Long-term antibiotics for Lyme disease remain one of the most debated issues in Lyme disease treatment. While treatment guidelines often recommend relatively short courses of antibiotics, many physicians report extending therapy when patients continue to experience symptoms.
A nationwide survey suggests that long-term antibiotics for Lyme disease may be more common in clinical practice than many experts expected.
In an annual cross-sectional survey of physicians practicing in Lyme-endemic areas, researchers found that a substantial number of patients received antibiotic treatment beyond standard short-course recommendations.
According to the survey:
20.3% of patients were treated for 5–8 weeks
35.6% were treated for more than 8 weeks
“A surprisingly large proportion of respondents reported receiving more than 8 weeks of antibiotic treatment for Lyme disease,” writes Hook in the journal Ticks and Tick-borne Diseases.
The survey asked physicians practicing in Lyme-endemic areas about their experiences diagnosing and treating Lyme disease.
These findings suggest that extended antibiotic therapy for Lyme disease occurs more frequently in clinical practice than many guidelines assume.
The debate over treatment duration reflects a broader challenge in Lyme disease care—balancing guideline recommendations with individual patient response—a tension explored further in Why Lyme Disease Tests the Limits of Medicine.
Why Do Some Patients Receive Long-Term Antibiotics for Lyme Disease?
Prolonged treatment for Lyme disease is not new.
The survey authors note that many physicians report prescribing longer treatment courses despite existing treatment guidelines.
“Many respondents reporting receiving prolonged therapy is concordant with other reports of providers’ non-adherence to or unfamiliarity with Lyme disease treatment guidelines,” Hook writes.
However, the survey did not examine why clinicians chose extended therapy, since researchers did not have access to patient records or physician decision-making.
In clinical practice, physicians may extend treatment when patients:
continue to experience significant symptoms
present with later-stage or complicated disease
show an incomplete response to initial therapy
have possible tick-borne coinfections
Because Lyme disease can affect multiple body systems and may evolve over time, treatment decisions are often individualized based on a patient’s clinical course.
The Ongoing Debate Over Extended Lyme Disease Treatment
The survey authors reiterate a commonly cited position regarding treatment duration:
“There is no scientific evidence of clinical benefit from antibiotic treatment longer than current guidelines recommend.”
“Several controlled trials showed no benefit in prolonged antibiotic therapy for patients with persistent symptoms.”
Based on these conclusions, the authors suggest that physician education could reduce the use of longer antibiotic courses, particularly because of concerns about antibiotic-related complications and the development of resistance.
Persistent symptoms following Lyme disease treatment remain a significant clinical challenge. Some studies report that a portion of patients continue to experience fatigue, pain, or cognitive difficulties after initial therapy.
Clinical Perspective
In my experience, most physicians treating Lyme disease are well aware of the existing recommendations that limit antibiotic therapy to relatively short treatment courses.
However, clinical decisions are rarely based on guidelines alone. Physicians must also consider individual patient response, disease severity, and the possibility of persistent symptoms.
I am an author of the International Lyme and Associated Diseases Society (ILADS) treatment guidelines, which recommend that treatment decisions be individualized based on clinical response rather than a fixed duration of therapy.
The tension between guideline-driven limits and clinical decision-making is not simply a scientific disagreement. In many cases it becomes an ethical question about how physicians should respond when patients remain ill after standard treatment.
I explore this issue further in the article on the
ethics of Lyme disease diagnosis and treatment.
What the Survey Tells Us
The survey highlights an important reality: treatment decisions for Lyme disease vary widely in clinical practice.
Some physicians follow strict guideline timelines, while others extend treatment when patients do not improve.
Understanding these differences is important for both clinicians and patients navigating the complex decisions surrounding Lyme disease care.
The debate over long-term antibiotics for Lyme disease is likely to continue as clinicians balance treatment guidelines with the realities of patient care.
Related Articles
Failure rates still too high for the treatment of Lyme disease
Over 20% of Lyme disease patients remain ill after treatment
Johns Hopkins study supports early identification of Lyme disease patients for re-treatment
Reference
Hook SA, Nelson CA, Mead PS. U.S. public’s experience with ticks and tick-borne diseases: Results from national HealthStyles surveys. Ticks Tick Borne Dis. 2015;6(4):483-488.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
The incorrect dogma comes from our ‘friends’ at the IDSA.
These guys are still clinging to their 2006 guidelines .. the guidelines they updated a while back reporting that old guidelines are what’s for dinner … I’m not sure why they are getting paid …
So, what is the more up to date time line of treatment these days? I have been on antibiotics for 4 months now and my PA is saying it could be as long as 18 months.
Kent
I find it difficult to predict how long the treatment will last. I have patients who are better much quicker than they imagined I have had to individualize treatment for my patients.